Abpro (NASDAQ:ABP) Now Covered by Analysts at Maxim Group

Maxim Group began coverage on shares of Abpro (NASDAQ:ABP) in a research note issued to investors on Monday morning,Benzinga reports. The brokerage issued a buy rating and a $4.00 price objective on the stock.

Abpro Stock Down 9.1 %

Shares of ABP opened at $0.76 on Monday. Abpro has a fifty-two week low of $0.75 and a fifty-two week high of $13.00. The business has a 50-day moving average price of $1.41.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the business. Jane Street Group LLC bought a new position in shares of Abpro in the fourth quarter worth $37,000. LMR Partners LLP purchased a new position in Abpro during the 4th quarter valued at about $112,000. Geode Capital Management LLC purchased a new position in Abpro during the 4th quarter valued at about $53,000. AQR Arbitrage LLC bought a new stake in shares of Abpro during the fourth quarter valued at about $157,000. Finally, Atlas Merchant Capital LLC purchased a new stake in shares of Abpro in the fourth quarter worth about $157,000. 23.30% of the stock is owned by institutional investors.

About Abpro

Abpro Holdings Inc is a biotechnology company. The company’s mission is to improve the lives of mankind facing severe and life-threatening diseases with next-generation antibody therapies. Abpro Holdings Inc, formerly known as Atlantic Coastal Acquisition Corp. II, is based in WOBURN, Mass.